Nasopharyngeal carcinoma secondary prevention: Difference between revisions
YazanDaaboul (talk | contribs) |
YazanDaaboul (talk | contribs) |
||
Line 20: | Line 20: | ||
:Physical exam | :Physical exam | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Every 1-3 months | *Every 1-3 months during the 1st year after treatment | ||
*Every 2-6 months | *Every 2-6 months during the 2nd year after treatment | ||
*Every 4-8 months between | *Every 4-8 months between the 3rd and 5th years after treatment | ||
*Annually thereafter | *Annually thereafter | ||
|- | |- | ||
Line 28: | Line 28: | ||
:Nasendoscopy | :Nasendoscopy | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Immediately | *Immediately following radiation therapy | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | ||
Line 36: | Line 36: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Scans are performed at routine intervals as follows: | Scans are performed at routine intervals as follows: | ||
*Baseline scanning is | *Baseline scanning is performed at 3-6 months after treatment, further scans are scheduled based on finding of physical exam and symptoms experienced by the patient | ||
*Scanning for asymptomatic patients is not | *Scanning for asymptomatic patients is not recommended | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | ||
:Thyroid hormone testing | :Thyroid hormone testing | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Thyroid stimulating hormone testing every 12 months if neck | *Thyroid stimulating hormone testing every 12 months if the neck was exposed to radiation therapy | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | | ||
:Dental screening | :Dental screening | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Only recommended if oral cavity | *Only recommended if oral cavity was exposed to radiations | ||
|- | |- | ||
|} | |} |
Revision as of 15:51, 29 September 2015
Nasopharyngeal carcinoma Microchapters |
Differentiating Nasopharyngeal carcinoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Nasopharyngeal carcinoma secondary prevention On the Web |
American Roentgen Ray Society Images of Nasopharyngeal carcinoma secondary prevention |
Risk calculators and risk factors for Nasopharyngeal carcinoma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2]
Overview
Secondary prevention measures of nasopharyneal cancer include routine physical examination and imaging at scheduled intervals after treatment. Dental screening and screening for thyroid cancers are recommended among patients who had received radiation therapy to the oral cavity and cervical region, respectively.
Secondary Prevention
Follow up after treatment
Patients treated for nasopharyngeal carcinoma should follow-up for secondary prevention. Follow-up measures are shown in the table below:[1]
Follow up | Description |
---|---|
|
|
|
|
|
Scans are performed at routine intervals as follows:
|
|
|
|
|
Table adapted from Pfister DG, et al. Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013;11(8):917-23.[1]
References
- ↑ 1.0 1.1 Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ; et al. (2013). "Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines". J Natl Compr Canc Netw. 11 (8): 917–23. PMID 23946171.